A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Diane Hershock, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rigshospitalet Uni of Hospital of Copenhagen
Copenhagen, Denmark
- Odense University Hospital
Odense C, Denmark
- Netherlands Cancer Institute Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
- University Medical Center Groningen
Groningen, Netherlands
- Erasmus Medical Center
Rotterdam, Netherlands
- Haukeland University Hospital
Bergen, Norway
- Utprøvingsenheten, Oslo University Hospital Radiumhospitalet
Oslo, Norway
- Skane University Hospital Lund
Lund, Sweden
- Karolinska University Hospital Solna
Stockholm, Sweden
- Yale Cancer Center
New Haven, Connecticut, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2018
- Primary completion
- 10 Sept 2025
- Completion
- 10 Sept 2025
- Last update posted
- 9 Oct 2025
- Registered enrollment
- 83
- Registry id
- NCT03522142
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.